-
1
-
-
0034721255
-
Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
-
Shapiro AMJ, Lakey JRT, Ryan EA et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
-
(2000)
N Engl J Med
, vol.343
, pp. 230-238
-
-
Shapiro, A.M.J.1
Lakey, J.R.T.2
Ryan, E.A.3
-
2
-
-
19544383042
-
Strategic opportunities in clinical islet transplantation
-
Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplant 2005; 79: 1304-1307.
-
(2005)
Transplant
, vol.79
, pp. 1304-1307
-
-
Shapiro, A.M.1
Lakey, J.R.2
Paty, B.W.3
Senior, P.A.4
Bigam, D.L.5
Ryan, E.A.6
-
3
-
-
0141987875
-
Edmonton's islet success has indeed been replicated elsewhere
-
Shapiro AMJ, Ricordi C, Hering BJ. Edmonton's islet success has indeed been replicated elsewhere. Lancet 2003; 362: 1242.
-
(2003)
Lancet
, vol.362
, pp. 1242
-
-
Shapiro, A.M.J.1
Ricordi, C.2
Hering, B.J.3
-
4
-
-
22844450663
-
Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience
-
Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046.
-
(2005)
Am J Transplant
, vol.5
, pp. 2037-2046
-
-
Froud, T.1
Ricordi, C.2
Baidal, D.A.3
-
5
-
-
13844265752
-
Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes
-
Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
-
(2005)
JAMA
, vol.293
, pp. 830-835
-
-
Hering, B.J.1
Kandaswamy, R.2
Ansite, J.D.3
-
6
-
-
21344462346
-
Five-year follow-up after clinical islet transplantation
-
Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
-
(2005)
Diabetes
, vol.54
, pp. 2060-2069
-
-
Ryan, E.A.1
Paty, B.W.2
Senior, P.A.3
-
7
-
-
0034106289
-
A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts
-
Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
-
(2000)
Hepatology
, vol.31
, pp. 864-871
-
-
Malinchoc, M.1
Kamath, P.S.2
Gordon, F.D.3
Peine, C.J.4
Rank, J.5
Ter Borg, P.C.6
-
8
-
-
0035146422
-
A model to predict survival in patients with end-stage liver disease
-
Kamath PS, Wiesner RH, Malinchoc M et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
-
(2001)
Hepatology
, vol.33
, pp. 464-470
-
-
Kamath, P.S.1
Wiesner, R.H.2
Malinchoc, M.3
-
9
-
-
0037223652
-
Model for end-stage liver disease (MELD) and allocation of donor livers
-
Wiesner R, Edwards E, Freeman R et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 91-96.
-
(2003)
Gastroenterology
, vol.124
, pp. 91-96
-
-
Wiesner, R.1
Edwards, E.2
Freeman, R.3
-
10
-
-
0842346309
-
Results of the first year of the new liver allocation plan
-
Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004; 10: 7-15.
-
(2004)
Liver Transpl
, vol.10
, pp. 7-15
-
-
Freeman, R.B.1
Wiesner, R.H.2
Edwards, E.3
Harper, A.4
Merion, R.5
Wolfe, R.6
-
11
-
-
3042826634
-
Improving liver allocation: MELD and PELD
-
Freeman RB, Jr., Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4 (Suppl 9): 114-131.
-
(2004)
Am J Transplant
, vol.4
, Issue.9 SUPPL.
, pp. 114-131
-
-
Freeman Jr., R.B.1
Wiesner, R.H.2
Roberts, J.P.3
McDiarmid, S.4
Dykstra, D.M.5
Merion, R.M.6
-
12
-
-
0032573565
-
Adult living donor liver transplantation using a right hepatic lobe
-
Wachs ME, Bak TE, Karrer FM et al. Adult living donor liver transplantation using a right hepatic lobe. Transplant 1998; 66: 1313-1316.
-
(1998)
Transplant
, vol.66
, pp. 1313-1316
-
-
Wachs, M.E.1
Bak, T.E.2
Karrer, F.M.3
-
13
-
-
0033610250
-
Right lobe living donor liver transplantation
-
Marcos A, Fisher RA, Ham JM et al. Right lobe living donor liver transplantation. Transplant 1999; 68: 798-803.
-
(1999)
Transplant
, vol.68
, pp. 798-803
-
-
Marcos, A.1
Fisher, R.A.2
Ham, J.M.3
-
14
-
-
0037468422
-
A survey of liver transplantation from living adult donors in the United States
-
Brown RS, Jr., Russo MW, Lai M et al. A survey of liver transplantation from living adult donors in the United States. N Engl J Med 2003; 348: 818-825.
-
(2003)
N Engl J Med
, vol.348
, pp. 818-825
-
-
Brown Jr., R.S.1
Russo, M.W.2
Lai, M.3
-
15
-
-
0037442204
-
Complications and long-term outcome of living liver donors: A survey of 1,508 cases in five Asian centers
-
Lo CM. Complications and long-term outcome of living liver donors: A survey of 1,508 cases in five Asian centers. Transplant 2003; 75 (3 Suppl): S12-S15.
-
(2003)
Transplant
, vol.75
, Issue.3 SUPPL.
-
-
Lo, C.M.1
-
16
-
-
0142217426
-
Early and late complications in the right-lobe adult living donor
-
Pomfret EA. Early and late complications in the right-lobe adult living donor. Liver Transpl 2003; 9(10 Suppl 2): S45-S49.
-
(2003)
Liver Transpl
, vol.9
, Issue.10 SUPPL. 2
-
-
Pomfret, E.A.1
-
17
-
-
3042519295
-
Lessons learned from one hundred right lobe living donor liver transplants
-
Lo CM, Fan ST, Liu CL et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004; 240: 151-158.
-
(2004)
Ann Surg
, vol.240
, pp. 151-158
-
-
Lo, C.M.1
Fan, S.T.2
Liu, C.L.3
-
18
-
-
0842289174
-
Right living donor liver transplantation: An option for adult patients: Single institution experience with 74 patients
-
Malago M, Testa G, Frilling A et al. Right living donor liver transplantation: An option for adult patients: Single institution experience with 74 patients. Ann Surg 2003; 238: 853-862.
-
(2003)
Ann Surg
, vol.238
, pp. 853-862
-
-
Malago, M.1
Testa, G.2
Frilling, A.3
-
19
-
-
19944428273
-
Adult living donor versus deceased donor liver transplantation: A 6-year single center experience
-
Maluf DG, Stravitz RT, Cotterell AH et al. Adult living donor versus deceased donor liver transplantation: A 6-year single center experience. Am J Transplant 2005; 5: 149-156.
-
(2005)
Am J Transplant
, vol.5
, pp. 149-156
-
-
Maluf, D.G.1
Stravitz, R.T.2
Cotterell, A.H.3
-
20
-
-
33644900958
-
Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: Program experience and lessons learned
-
Pomposelli JJ, Verbesey J, Simpson MA et al. Improved survival after live donor adult liver transplantation (LDALT) using right lobe grafts: Program experience and lessons learned. Am J Transplant 2006; 6: 589-598.
-
(2006)
Am J Transplant
, vol.6
, pp. 589-598
-
-
Pomposelli, J.J.1
Verbesey, J.2
Simpson, M.A.3
-
21
-
-
24944586521
-
Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL Consortium
-
Olthoff KM, Merion RM, Ghobrial RM et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: A report from the A2ALL Consortium. Ann Surg 2005; 242: 314-323, discussion.
-
(2005)
Ann Surg
, vol.242
, pp. 314-323
-
-
Olthoff, K.M.1
Merion, R.M.2
Ghobrial, R.M.3
-
22
-
-
33645693609
-
Liver and intestine transplantation in the United States: 1995-2004
-
Shiffman ML, Saab S, Feng S et al. Liver and intestine transplantation in the United States: 1995-2004. Am J Transplant 2006; 6: 1170-1187.
-
(2006)
Am J Transplant
, vol.6
, pp. 1170-1187
-
-
Shiffman, M.L.1
Saab, S.2
Feng, S.3
-
23
-
-
11844249361
-
Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation
-
Shergill AK, Khalili M, Straley S et al. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation. Am J Transplant 2005; 5: 118-124.
-
(2005)
Am J Transplant
, vol.5
, pp. 118-124
-
-
Shergill, A.K.1
Khalili, M.2
Straley, S.3
-
24
-
-
0042360213
-
Chronic renal failure after transplantation of a nonrenal organ
-
Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
-
(2003)
N Engl J Med
, vol.349
, pp. 931-940
-
-
Ojo, A.O.1
Held, P.J.2
Port, F.K.3
-
25
-
-
19244366021
-
Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
-
Eisen HJ, Tuzcu EM, Dorent R et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003; 349: 847-858.
-
(2003)
N Engl J Med
, vol.349
, pp. 847-858
-
-
Eisen, H.J.1
Tuzcu, E.M.2
Dorent, R.3
-
26
-
-
20844461132
-
Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
-
Keogh A, Richardson M, Ruygrok P et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial. Circulation 2004; 110: 2694-2700.
-
(2004)
Circulation
, vol.110
, pp. 2694-2700
-
-
Keogh, A.1
Richardson, M.2
Ruygrok, P.3
-
27
-
-
20944441873
-
Multicenter intravascular ultrasound validation study among heart transplant recipients: Outcomes after five years
-
Kobashigawa JA, Tobis JM, Starling RC et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: Outcomes after five years. J Am Coll Cardiol 2005; 45: 1532-1537.
-
(2005)
J Am Coll Cardiol
, vol.45
, pp. 1532-1537
-
-
Kobashigawa, J.A.1
Tobis, J.M.2
Starling, R.C.3
-
28
-
-
0035892018
-
Long-term mechanical left ventricular assistance for end-stage heart failure
-
Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001; 345: 1435-1443.
-
(2001)
N Engl J Med
, vol.345
, pp. 1435-1443
-
-
Rose, E.A.1
Gelijns, A.C.2
Moskowitz, A.J.3
-
29
-
-
16244384594
-
Thoracic organ transplantation in the United States, 1994-2003
-
Barr ML, Bourge RC, Orens JB et al. Thoracic organ transplantation in the United States, 1994-2003. Am J Transplant 2005; 5 (4 Pt 2): 934-949.
-
(2005)
Am J Transplant
, vol.5
, Issue.4 PART 2
, pp. 934-949
-
-
Barr, M.L.1
Bourge, R.C.2
Orens, J.B.3
-
30
-
-
3542995707
-
Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies?
-
Meier-Kriesche HU, Schold JD, Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 2004; 4: 1289-1295.
-
(2004)
Am J Transplant
, vol.4
, pp. 1289-1295
-
-
Meier-Kriesche, H.U.1
Schold, J.D.2
Kaplan, B.3
-
31
-
-
23944502334
-
Costimulation blockade with belatacept in renal transplantation
-
Vincenti F, Larsen C, Durrbach A et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353: 770-781.
-
(2005)
N Engl J Med
, vol.353
, pp. 770-781
-
-
Vincenti, F.1
Larsen, C.2
Durrbach, A.3
-
32
-
-
33644833287
-
Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression
-
Flechner SM, Friend PJ, Brockmann J et al. Alemtuzumab induction and sirolimus plus mycophenolate mofetil maintenance for CNI and steroid-free kidney transplant immunosuppression. Am J Transplant 2005; 5: 3009-3014.
-
(2005)
Am J Transplant
, vol.5
, pp. 3009-3014
-
-
Flechner, S.M.1
Friend, P.J.2
Brockmann, J.3
-
33
-
-
27744481221
-
Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin
-
Kirk AD, Mannon RB, Kleiner DE et al. Results from a human renal allograft tolerance trial evaluating T-cell depletion with alemtuzumab combined with deoxyspergualin. Transplantation 2005; 80: 1051-1059.
-
(2005)
Transplantation
, vol.80
, pp. 1051-1059
-
-
Kirk, A.D.1
Mannon, R.B.2
Kleiner, D.E.3
-
34
-
-
20144389244
-
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath
-
Shapiro R, Basu A, Tan H et al. Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg 2005; 200: 505-515.
-
(2005)
J Am Coll Surg
, vol.200
, pp. 505-515
-
-
Shapiro, R.1
Basu, A.2
Tan, H.3
-
35
-
-
33644676984
-
Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results
-
Kaufman DB, Leventhal JR, Axelrod D, Gallon LG, Parker MA, Stuart FP. Alemtuzumab induction and prednisone-free maintenance immunotherapy in kidney transplantation: Comparison with basiliximab induction - Long-term results. Am J Transplant 2005; 5: 2539-2548.
-
(2005)
Am J Transplant
, vol.5
, pp. 2539-2548
-
-
Kaufman, D.B.1
Leventhal, J.R.2
Axelrod, D.3
Gallon, L.G.4
Parker, M.A.5
Stuart, F.P.6
-
36
-
-
0038805159
-
Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study
-
Knechtle SJ, Pirsch JD, Fechner H et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: Results of a pilot study. Am J Transplant 2003; 3: 722-730.
-
(2003)
Am J Transplant
, vol.3
, pp. 722-730
-
-
Knechtle, S.J.1
Pirsch, J.D.2
Fechner, H.3
-
38
-
-
1342325540
-
Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study
-
Budde K, Curtis J, Knoll G et al. Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study. Am J Transplant 2004; 4: 237-243.
-
(2004)
Am J Transplant
, vol.4
, pp. 237-243
-
-
Budde, K.1
Curtis, J.2
Knoll, G.3
-
39
-
-
1342346699
-
Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
-
Salvadori M, Holzer H, de Mattos A et al. Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 2004; 4: 231-236.
-
(2004)
Am J Transplant
, vol.4
, pp. 231-236
-
-
Salvadori, M.1
Holzer, H.2
De Mattos, A.3
-
40
-
-
3142734960
-
The effects of FK778 in combination with tacrolimus and steroids: A phase II multicenter study in renal transplant patients
-
Vanrenterghem Y, van Hooff JP, Klinger M et al. The effects of FK778 in combination with tacrolimus and steroids: A phase II multicenter study in renal transplant patients. Transplant 2004; 78: 9-14.
-
(2004)
Transplant
, vol.78
, pp. 9-14
-
-
Vanrenterghem, Y.1
Van Hooff, J.P.2
Klinger, M.3
-
41
-
-
4744351965
-
Effect of sirolimus withdrawal in patients with deteriorating renal function
-
Kaplan B, Schold J, Srinivas T et al. Effect of sirolimus withdrawal in patients with deteriorating renal function. Am J Transplant 2004; 4: 1709-1712.
-
(2004)
Am J Transplant
, vol.4
, pp. 1709-1712
-
-
Kaplan, B.1
Schold, J.2
Srinivas, T.3
-
42
-
-
21644457432
-
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation
-
Oberbauer R, Segoloni G, Campistol JM et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transplant Int 2005; 18: 22-28.
-
(2005)
Transplant Int
, vol.18
, pp. 22-28
-
-
Oberbauer, R.1
Segoloni, G.2
Campistol, J.M.3
-
43
-
-
2942534405
-
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years
-
Mota A, Arias M, Taskinen EI et al. Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years. Am J Transplant 2004; 4: 953-961.
-
(2004)
Am J Transplant
, vol.4
, pp. 953-961
-
-
Mota, A.1
Arias, M.2
Taskinen, E.I.3
-
44
-
-
7244220158
-
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years
-
Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 1776-1785.
-
(2004)
Am J Transplant
, vol.4
, pp. 1776-1785
-
-
Flechner, S.M.1
Kurian, S.M.2
Solez, K.3
-
45
-
-
33644889043
-
Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus
-
Larson TS, Dean PG, Stegall MD et al. Complete avoidance of calcineurin inhibitors in renal transplantation: A randomized trial comparing sirolimus and tacrolimus. Am J Transplant 2006; 6: 514-522.
-
(2006)
Am J Transplant
, vol.6
, pp. 514-522
-
-
Larson, T.S.1
Dean, P.G.2
Stegall, M.D.3
-
46
-
-
28444454862
-
Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: Results from a prospective, randomized trial
-
Hazzan M, Labalette M, Copin MC et al. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: Results from a prospective, randomized trial. J Am Soc Nephrol 2005; 16: 2509-2516.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 2509-2516
-
-
Hazzan, M.1
Labalette, M.2
Copin, M.C.3
-
47
-
-
9244234438
-
Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials
-
Pascual J, Quereda C, Zamora J, Hernandez D. Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: A meta-analysis of randomized, controlled trials. Transplant 2004; 78: 1548-1556.
-
(2004)
Transplant
, vol.78
, pp. 1548-1556
-
-
Pascual, J.1
Quereda, C.2
Zamora, J.3
Hernandez, D.4
-
48
-
-
33644673045
-
Prednisone-free maintenance immunosuppression-a 5-year experience
-
Matas AJ, Kandaswamy R, Gillingham KJ et al. Prednisone-free maintenance immunosuppression-a 5-year experience. Am J Transplant 2005; 5: 2473-2478.
-
(2005)
Am J Transplant
, vol.5
, pp. 2473-2478
-
-
Matas, A.J.1
Kandaswamy, R.2
Gillingham, K.J.3
-
49
-
-
22844452587
-
Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results
-
Anil Kumar MS, Moritz MJ, Saaed MI et al. Avoidance of chronic steroid therapy in african american kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am J Transplant 2005; 5: 1976-1985.
-
(2005)
Am J Transplant
, vol.5
, pp. 1976-1985
-
-
Anil Kumar, M.S.1
Moritz, M.J.2
Saaed, M.I.3
-
50
-
-
0027281172
-
Capillary deposition of C4d complement fragment and early renal graft loss
-
Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338.
-
(1993)
Kidney Int
, vol.43
, pp. 1333-1338
-
-
Feucht, H.E.1
Schneeberger, H.2
Hillebrand, G.3
-
51
-
-
10744233377
-
Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection
-
Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria - An addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708-714.
-
(2003)
Am J Transplant
, vol.3
, pp. 708-714
-
-
Racusen, L.C.1
Colvin, R.B.2
Solez, K.3
-
52
-
-
33644789720
-
Humoral rejection of organ allografts
-
Moll S, Pascual M. Humoral rejection of organ allografts. Am J Transplant 2005; 5: 2611-2618.
-
(2005)
Am J Transplant
, vol.5
, pp. 2611-2618
-
-
Moll, S.1
Pascual, M.2
-
53
-
-
27844510762
-
Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts
-
Hippen BE, DeMattos A, Cook WJ, Kew CE, Gaston RS. Association of CD20+ infiltrates with poorer clinical outcomes in acute cellular rejection of renal allografts. Am J Transplant 2005; 5: 2248-2252.
-
(2005)
Am J Transplant
, vol.5
, pp. 2248-2252
-
-
Hippen, B.E.1
DeMattos, A.2
Cook, W.J.3
Kew, C.E.4
Gaston, R.S.5
-
54
-
-
0036191890
-
Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification
-
Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002; 13: 779-787.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 779-787
-
-
Mauiyyedi, S.1
Crespo, M.2
Collins, A.B.3
-
55
-
-
0036707891
-
Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection
-
Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380.
-
(2002)
J Am Soc Nephrol
, vol.13
, pp. 2371-2380
-
-
Regele, H.1
Bohmig, G.A.2
Habicht, A.3
-
56
-
-
3042741071
-
Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan
-
Takahashi K, Saito K, Takahara S et al. Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan. Am J Transplant 2004; 4: 1089-1096.
-
(2004)
Am J Transplant
, vol.4
, pp. 1089-1096
-
-
Takahashi, K.1
Saito, K.2
Takahara, S.3
-
57
-
-
3542999932
-
Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses
-
Agarwal A, Vieira CA, Book BK, Sidner RA, Fineberg NS, Pescovitz MD. Rituximab, anti-CD20, induces in vivo cytokine release but does not impair ex vivo T-cell responses. Am J Transplant 2004; 4: 1357-1360.
-
(2004)
Am J Transplant
, vol.4
, pp. 1357-1360
-
-
Agarwal, A.1
Vieira, C.A.2
Book, B.K.3
Sidner, R.A.4
Fineberg, N.S.5
Pescovitz, M.D.6
-
58
-
-
21144443075
-
Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations
-
Hirsch HH, Brennan DC, Drachenberg CB et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplant 2005; 79: 1277-1286.
-
(2005)
Transplant
, vol.79
, pp. 1277-1286
-
-
Hirsch, H.H.1
Brennan, D.C.2
Drachenberg, C.B.3
-
59
-
-
31644434617
-
BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients
-
Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834-1839.
-
(2005)
Kidney Int
, vol.68
, pp. 1834-1839
-
-
Vasudev, B.1
Hariharan, S.2
Hussain, S.A.3
Zhu, Y.R.4
Bresnahan, B.A.5
Cohen, E.P.6
-
60
-
-
33644882722
-
Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results
-
Kaufman DB, Leventhal JR, Gallon LG, Parker MA. Alemtuzumab induction and prednisone-free maintenance immunotherapy in simultaneous pancreas-kidney transplantation comparison with rabbit antithymocyte globulin induction - Long-term results. Am J Transplant 2006; 6: 331-339.
-
(2006)
Am J Transplant
, vol.6
, pp. 331-339
-
-
Kaufman, D.B.1
Leventhal, J.R.2
Gallon, L.G.3
Parker, M.A.4
-
61
-
-
0344630326
-
Survival after pancreas transplantation in patients with diabetes and preserved kidney function
-
Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 2817-2823.
-
(2003)
JAMA
, vol.290
, pp. 2817-2823
-
-
Venstrom, J.M.1
McBride, M.A.2
Rother, K.I.3
Hirshberg, B.4
Orchard, T.J.5
Harlan, D.M.6
-
63
-
-
14644437155
-
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
-
Lake JR, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant 2005; 5: 549-557.
-
(2005)
Am J Transplant
, vol.5
, pp. 549-557
-
-
Lake, J.R.1
Shorr, J.S.2
Steffen, B.J.3
Chu, A.H.4
Gordon, R.D.5
Wiesner, R.H.6
|